Dewmar International BMC, Inc. Announces 2014 Growth Plans

HOUSTON - Feb. 5, 2014 - PRLog -- Dewmar International BMC, Inc.   ("Dewmar" or "Company") announced today growth initiatives for the brand management company, as well as its flagship product, Lean Slow Motion Potion (“Brand”) which is expected to achieve a 300% increase during Q1-2014 compared to previous quarter as the Company prepares to fulfill a significant number of outstanding purchase orders for Lean from distributors and refill displays at Walmart.

Most importantly, for Dewmar and its shareholders, the company has successfully managed through a series of ‘toxic’ financing facilities with two New York City investment groups that converted over 1.27 billion shares which ultimately placed downward pressure on the company’s market price, dropping it from a high of $0.50.  Dewmar is proud to announce that there are no additional outstanding toxic financing facilities that would allow debtors to convert any more Company stock as of this writing.

Additionally, Dewmar has entered into strong relationships with new bottlers and warehousing facilities to avoid issues faced in 2013 pertaining to higher production run costs and unsuspecting storage issues  that resulted in significant inventory losses this past summer. Lastly, Dewmar has deflected several frivolous lawsuits filed by one disgruntled competitor and their cohorts. With these accomplishments, a strong leading Brand and quality channel partners, Dewmar is well positioned for growth in 2014.

Lean’s entrance into shelf space at Walmart is a significant achievement, as is the product cold vault displays at Walgreens in Des Moines and Omaha, cultivated by long-standing independent distributors of Lean based in Nebraska. Dewmar plans to significantly expand upon these existing accounts as the year progresses. Further, the 2014 Lean Slow Motion Potion rebranding project with an aim to broaden Brand appeal across a wider consumer demographic is anticipated to have a significant effect on an increase in sales.

“Lean has separated itself from the conversation of ‘fly by night’ relaxation brands that have come and gone over the years,” said Marco Moran, CEO of Dewmar. “Our patience has paid off. We are one of the few remaining companies in the relaxation space that’s well positioned for growth; in fact, in 2008 the category consisted of over 30 brands which has dwindled down to 5 now who capture the majority of the U.S. market. Moreover, our ability to seek out proper distribution channels and cultivate strong relationships with distributors has resulted in significant loyalty to the brand from both consumers and the beverage industry itself. In 2014, Dewmar anticipates expansion into newer regions of the country, by taking advantage of government contracts via SAMS registration and by adding skilled sales professionals to our staff. The company plans to gain access to a variety of international markets through newly cultivated relationships. It is essential that Dewmar continue to grow strategically, building confidence in old markets while making introductions into new sales channels.”

Additionally, due to the skyrocketing industrial hemp and medical marijuana industry, Dewmar also announces plans to aggressively seek within this emerging space numerous partnerships, joint ventures, exclusive product licensing agreements and/or acquisitions of product lines that would add value to the Company’s bottom line. Dewmar is discussing the pursuit in development of new food/beverage products that contain hemp oil extracts and other cannabinoid-related ingredients that qualify to be sold in all 50 states.

The Company has also increased the number of authorized shares to 4.5 billion, the purpose being to have available, only if necessary, some additional restricted shares to be utilized as part of the acquisition of profitable entities or for the exchange of services that would be extremely beneficial toward the growth of Dewmar.

Dewmar proudly announces that due to a massive response from investors in DEWM stock volume and price increases following the December 11, 2013 press release announcing Lean Slow Motion Potion’s presence in Walmart, an agent of the Financial Industry Regulatory Authority (FINRA) conducted a routine 30 minute interview with the CEO about Dewmar’s history, business practices and in-depth relationship with Walmart. FINRA is dedicated to investor protection and market integrity through effective and efficient regulation of the securities industry. Dewmar immediately complied by providing all such requested information as to be in full and immediate compliance.

Dewmar prides itself in working hard to ensure the long term success of the Company and seeks to comply with all SEC rules to report material events accordingly. As such, all investors will be responded to in a public forum by way of press release or public recording, no individual emails or calls will be responded to with regards to any Company updates.

About Dewmar International BMC, Inc.
Dewmar International BMC, Inc. is a leading provider of consumer brands to global markets. The Company's flagship product, LEAN SLOW MOTION POTION™ whose three flavors are Yella, Purp and Easta Pink, is rated as one of the top 3 national selling relaxation beverages currently available in the U.S. market, Trinidad & Tobago, Puerto Rico and Mexico. The company has offices in Clinton, MS; Las Vegas, NV and Houston, TX.

For more information about our Company please visit us at http://www.DewmarInternational.com or http://slowmotionpotion.com/. If you are a distributor or retailer inquiring about purchasing our product for resale, please contact us at 1-877-SIP-LEAN or 1-877-747-5326. If you are an Investor please contact us at InvestorRelations@DewmarInternational.com

Safe Harbor Statement
This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, general economic conditions and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.